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Abstract
The interaction between TiO2 nanoparticles (NPs) and inflammatory cytokines, including CXCL8, a clinically 
relevant pro-inflammatory chemokine, was investigated. TiO2 is present in tissues adjacent to failing 
implanted Ti (titanium) devices. TiO2 NPs were shown to bind to CXCL8 in vitro, causing perturbation of 
quantification of CXCL8 by ELISA, in both simple and complex protein panels, in a dose-dependent manner. 
Binding between TiO2 NPs and CXCL8 was demonstrated by protein gel electrophoresis. TiO2 NPs were 
also shown to inactivate the chemoattractant property of CXCL8 in a dose-dependent manner, suggesting 
that the binding between TiO2 NPs and CXCL8 is likely to be clinically relevant. The results of this study 
disputed the applicability of detection of CXCL8 by ELISA in systems where TiO2 NPs were present. Clinically, 
the disruption of neutrophil chemotaxis due to CXCL8 binding to TiO2 NPs might result in a hampered 
inflammatory response.
Keywords: Titanium dioxide, nanoparticles, cytokines, chemokines, neutrophils, chemotaxis.
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Introduction
Humans are exposed to nanoparticles (NPs) from a 
wide variety of sources and through a broad range 
of exposure routes. Consequently, considerable 
attention is given to both the potential hazards of NP 
exposures (Chan et al., 2011; Jin et al., 2011; Shukla et 
al., 2011; Yazdi et al., 2010) and also, contrastingly, to 
their therapeutic use (Holpuch et al., 2010; Zhang and 
Monteiro-Riviere, 2013). Many studies concerning the 
toxicology of NPs and their interactions with a wide 
range of tissues and cells continue to be reported. 
However, the modelling of NP exposures to tissues 
is complex, given the propensity for NP aggregation 
(Zhang, 2014) and for the NPs to strongly adsorb 
biomolecules to their surfaces (Xia et al., 2011). 
Consequently, at the cellular level, interactions 
are often with the NP surface biomolecule corona 
and not the particle itself (Tenzer et al., 2013). The 
ability of certain NPs to strongly adsorb soluble 
biomolecules also has implications for cell-to-cell 
signalling and it is conceivable that, whilst certain 
NPs may not be directly cytotoxic, they have the 
ability to subtly alter the composition (concentration 
and concentration gradient) of biomolecules in 
extracellular environments. How titanium (Ti) NPs 
may exert such indirect effects through perturbation 
of cell-to-cell signalling processes was explored using 
TiO2 NPs. TiO2 can be found in tissues surrounding 
implanted Ti devices associated with peri-prosthetic 
inflammation, likely in NP form (Addison et al., 2012). 
They are contained in many consumer products, such 
as cosmetics and sunscreens (Frohlich and Roblegg, 
2012), and are advocated for a variety of biomedical 
applications, such as drug delivery systems, cancer 
treatments and cell imaging techniques (Yin et al., 
2013).
 Biological responses to TiO2 surfaces have been 
studied in detail and are shown to be both favourable 
and predictable [presenting minimal immune cell 
activation and promoting favourable responses 
from structural cells, such as surface adhesion and 
cell proliferation (Lu et al., 2008)]. However, when 
TiO2 is reduced to ultrafine and nano-scale forms, 
very different cellular responses are reported (Silva 
et al., 2013). Potential exposure routes to TiO2 NPs 
include inhalation, absorption through dermal 
and mucous membranes and particles generated 
in situ around implanted devices (Addison et al., 
2012; Frohlich and Roblegg, 2012; Tucci et al., 2013). 
TiO2 NPs are shown to be directly toxic to epithelial 
cells in in vitro models (Gerloff et al., 2012; Gurr et 
al., 2005; Kocbek et al., 2010; Park et al., 2008; Singh 
et al., 2007; Srivastava et al., 2013) and to induce 
pulmonary inflammation in rodent models, following 
inhalational exposure (Bonner et al., 2013; Kobayashi 
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et al., 2009). Absorption of TiO2 NPs through the 
gastrointestinal mucosa is also demonstrated in 
animal models (Brun et al., 2014; Jani et al., 1990; Jani 
et al., 1994), leading to transmucosal distribution and 
cellular internalisation. In contrast to these findings, 
the toxicological effects of intravascular injected TiO2 
NPs are minimal and the majority of particles (92 %) 
localise to the liver 24 h post-infusion (Elgrabli et al., 
2015). Generation of a range of Ti species (including 
metallic and oxide NP forms) in situ is also shown in 
areas adjacent to implanted Ti prostheses and these 
products are presumed to subsequently interact 
with innate and acquired immune cell populations 
(Addison et al., 2012; Cadosch et al., 2009; Jonas et 
al., 2001, Olmedo et al., 2008, Torgersen et al., 1995). 
TiO2 NPs can be pro-inflammatory, increasing the 
production of pro-inflammatory cytokines and 
chemokines (herein referred to as inflammatory 
mediators), such as interleukin-8 (IL-8, also known as 
CXCL8) in mesenchymal and epithelial cells (Haleem-
Smith et al., 2012; Wilson et al., 2000) and tumour 
necrosis factor alpha (TNFα) and receptor activator 
of nuclear factor kappa-B (RANKL) in fibroblasts 
(Irshad et al., 2013; Qian et al., 2013). Biological 
responses are sensitive to particle size, speciation and 
morphology (Singh et al., 2007) and, whilst the direct 
cellular effects of TiO2 NPs have been investigated 
extensively, there is a paucity of data exploring the 
biological effects of TiO2 NPs within the extracellular 
environment.
 NPs possess high surface energy favouring 
biomolecular adsorption (Horie et al., 2013) and, 
whilst this is recognised in the literature, the impact 
on data interpretation from NP exposure assays is 
frequently underestimated or ignored (Kroll et al., 
2009). Where NPs are shown to induce or fail to 
induce cytokine expression measured by ELISAs, it 
is important to recognise that the assay result will 
be affected by any binding between the NPs and 
inflammatory mediators or components of the assay 
system (Irshad et al., 2013). Despite the plethora of 
data reported, few studies have acknowledged this 
issue. The presence of NPs within an ELISA system 
can result in adsorption of inflammatory mediators, 
as reported for carbon NPs adsorbing CXCL8 (Hsiao 
and Huang, 2011; Monteiro-Riviere and Inman, 2006) 
and TiO2 NPs adsorbing interleukin-6 (IL-6) (Veranth 
et al., 2007).
 Exposure to TiO2 NPs can stimulate the release of 
CXCL8 (as identified by ELISA) from a variety of cell 
types, including human endothelial cells (Peters et al., 
2004) and human lung epithelial cells (Wilson et al., 
2012). CXCL8 is a pro-inflammatory chemokine and a 
potent chemoattractant produced by a variety of cell 
types, specifically targeting neutrophils (Bickel, 1993). 
Therefore, CXCL8 is a key factor in the initiation and 
propagation of the inflammatory response. Other 
studies use ELISA techniques to identify CXCL8 
release in a context where TiO2 NPs are present, with 
no mention of the potential for CXCL8 depletion by 
the presence of TiO2 NPs (Peters et al., 2004; Singh et 
al., 2007).
 The aim of this study was to investigate how 
extracellular TiO2 NPs interact with a selection 
of inflammatory mediators involved in cell-to-
cell signalling [CXCL8, TNFα, interleukin 1-beta 
(IL1-β), IL-6, interferon-gamma (IFN-γ)] during 
inflammation, with specific emphasis on CXCL8 and 
human neutrophil or polymorphonuclear leukocyte 
(PMNL) chemotaxis. The effects of the presence of 
TiO2 NPs within an ELISA detection system on these 
inflammatory mediators was also established. Given 
the lack of previously reported evidence, our null 
hypothesis was that the presence of TiO2 NPs had 
no selective impact on the adsorption of extracellular 
inflammatory mediators.
Fig. 1. (a) Optical image and (b) schematic illustration of the “bridge” of the Insall chamber. (a) The 
image shows the channels scribed into the chamber and the position of the coverslip, represented by the 
large white rectangle. The inset rectangle shows the detail of the “bridge” area of the chamber, where 
a gradient of chemoattractant is formed. This area of the chamber is visualised throughout the assay.
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Materials and Methods
TiO2 NP (stimulus) preparation
TiO2 (powder, anatase form, purity 99.7 %, catalogue 
number 637254, Sigma-Aldrich, Gillingham, UK) in 
the form of nanoparticles with a particle size < 25 nm 
was selected. The powder was heat-treated at 200 °C 
for 30 min to minimise endotoxin contamination. 
TiO2 was added to sterile ultrapure water at 
mixing ratios of 0.05, 0.5 and 5 g in 50 mL of H2O 
to provide a stock concentration of 100, 1000 and 
10000 µg/mL. The TiO2 NP suspension was placed 
on ice and sonicated using a Branson Sonifier 250 
(Branson Ultrasonics, Danbury, CT, USA) according 
to the protocol described by Taurozzi et al., (2013). 
Briefly, a “standard ½ inch clean titanium horn” 
(manufacturer’s description) was inserted centrally 
within a 100 mL beaker to a depth of 10 mm from the 
base of the vessel. Sonication was performed using a 
50 W power output and 80 % duty cycle for 15 min. 
Sonication was conducted in a positive flow biological 
hood (MSC12, Thermo Fisher Scientific, Waltham, 
USA) to maintain aseptic conditions.
Enzyme-linked immunosorbent assays (ELISAs)
ELISAs (CXCL8, IF-γ, IL-1β, TNFα, IL-6) were 
performed using DuoSet ELISA kits (R&D systems, 
Bio-techne, Abingdon, UK) according to the 
manufacturer’s instructions. Capture antibodies 
were diluted in protein-free phosphate-buffered 
saline (PBS) and 100 µL per well were incubated 
overnight at room temperature or at 4 °C (target 
specific) in covered plates, to prevent evaporation 
or contamination. Then, plates were washed 3 times 
using PBS containing 0.05 % Tween-20 (Sigma-
Aldrich) and the excess blotted using absorbent 
paper. After washing, wells were blocked with 300 µL 
of either reagent diluent (RD), comprising 2-amino-
2-(hydroxymethyl)propane-1,3-diol (Tris)-buffered 
saline containing 0.05 % Tween-20 and 0.1 % bovine 
serum albumin (BSA; Sigma-Aldrich), or blocking 
buffer (PBS containing 1 % BSA), depending on 
the target. After 1 h, plates were washed again 
according to the same washing protocol and then 
used immediately or stored at 4 °C for no longer than 
48 h prior to use. The stated limits of detection from 
the manufacturer are 31.20-2,000 pg/mL.
 Disruption of ELISA assay performance by TiO2 
NPs was assessed. Standards were diluted according 
to the specific manufacturer’s protocols to produce 
high concentration standards. 100 ppm TiO2 NPs 
were added to the high concentration target standard, 
agitated for 30 s, incubated at room temperature 
(21 ± 3 °C) for 1 h and centrifuged at 800 ×g for 
5 min. Following centrifugation, the supernatant was 
aspirated and serially diluted to produce a panel of 
standard concentrations. Control standards without 
TiO2 NPs were also incubated and centrifuged 
as above prior to dilution. 100 µL of each sample 
standard, either containing TiO2 NPs or not, were 
added to a prepared well and incubated in a covered 
plate for 2 h at room temperature. Then, plates were 
washed 3 times using PBS-Tween-20, as previously 
described. After washing, streptavidin conjugated to 
horseradish peroxidase (HRP) was diluted according 
to the manufacturer’s instructions and 100 µL were 
added to each well and incubated for 20 min in the 
dark at room temperature. After 20 min, the plates 
were washed again. 100 µL of a 50 : 50 mix of H2O2 
and tetramethylbenzidine (TMB) is recommended 
by the manufacturer; however, in this work a TMB 
Liquid Substrate System for ELISA (Sigma-Aldrich) 
was used due to its improved safety profile. The plate 
was incubated for up to 20 min in the dark as per the 
manufacturer’s instructions. After incubation, 50 µL 
of 1 M H2SO4 were added to each well to stop the 
reaction and then absorbance was read at 450 nm 
(absorbance at 570 nm was subtracted to improve 
accuracy) in a plate reader (ELx800, BioTek, Winooski, 
VT, USA). To assess variability, ELISA kits from a 
second manufacturer were used (Abcam ELISA kits 
for CXCL8, IL-6 and IFN-γ; Abcam, Cambridge, UK). 
The methodology was similar to the one of the R&D 
kits and the protocol was followed according to the 
manufacturer’s instruction.
No. Preparation protocol Sample used
1 2000 pg/mL CXCL8 in PBS
2a 2000 pg/mL CXCL8 plus 1000 ppm TiO2 in PBS incubated 
for 1 h at room temperature then centrifuged at 800 ×g for 
5 min 
Supernatant 
2b TiO2 pellet washed in PBS and 
re-suspended
3a
1000 ppm TiO2 in PBS incubated for 1 h at room 
temperature then centrifuged at 800 ×g for 5 min 
Supernatant
3b TiO2 pellet washed in PBS and 
re-suspended
4 2000 pg/mL CXCL8 in 20 % human serum
5a 2000 pg/mL CXCL8 in 20 % human serum plus 1000 ppm 
TiO2 in PBS incubated for 1 h at room temperature then 
centrifuged at 800 ×g for 5 min
Supernatant
5b TiO2 pellet washed in PBS and 
re-suspended
Table 1. A summary of prepared samples for electrophoresis.
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Neutrophil chemotaxis
Following informed consent (UK NRES 10/H1208/48), 
venous blood was collected in 6 mL Vacutainer™ 
(17 IU/mL heparin) anticoagulant tubes (Greiner, 
Stonehouse, UK) from volunteer donors (n = 14), 7 
females and 7 males with a mean age of 27 ± 8 years 
(range: 20-45), who were not currently taking any 
anti-inflammatory or anti-microbial medication. 
The entire blood sample was layered gently over 
pre-prepared Percoll (GE Healthcare, Amersham, 
UK) gradients of 1.079 and 1.098 g/mL in a 25 mL 
centrifuge tube using a Pasteur pipette. Tubes were 
centrifuged for 8 min at 150 ×g followed immediately 
by 10 min at 1,200 ×g (Hettich Universal 320R, Hettich, 
Kirchlengern, Germany) to separate the neutrophil-
containing layer, which was then aspirated prior to 
erythrocyte lysis using 0.83 % NH4Cl containing 1 % 
KHCO3, 0.04 % EDTA and 0.25 % BSA. Once isolated, 
the neutrophil pellet was resuspended in glucose and 
cation-supplemented PBS [Roswell Park Memorial 
Institute (RPMI) medium] at a concentration of 
1 × 106 cells/mL. Cell viability was determined by 
trypan blue exclusion and was typically over 97 %.
 An Insall chamber (Muinonen-Martin et al., 
2010) was used to allow quantitative imaging of 
neutrophil chemotaxis, according to methods 
Fig. 2. (a-e) Plots of inflammatory mediators concentrations (replicate points shown) against absorbance 
(arbitrary units, AU) derived from ELISAs (n = 2 or n = 4) for the serially-diluted specific standard and for 
the serially-diluted specific standard following 24 h exposure to 100 ppm TiO2 NPs and centrifugation to 
remove insoluble contents. Additional ELISA validation for CXCL8, IFN-γ and IL-6 (n = 4) were performed 
using R&D (grey/black) and Abcam (orange/yellow) assay kits.
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described by Roberts et al., (2015). Briefly, 22 mm 
coverslips (VWR International, Lutterworth, UK) 
were washed in 0.2 M HCl, dried and blocked 
using 7.5 % BSA (Sigma-Aldrich). Neutrophils, as 
prepared above (800 µL of ~ 1 × 106 cells/mL), were 
pipetted onto the coverslip and incubated at room 
temperature for 20 min to allow adherence. Then, 
the coverslip was inverted and placed carefully 
onto the Insall chamber (Fig. 1). Excess RPMI was 
absorbed from the edges of the coverslip to avoid 
flooding of the chamber and to allow the potential 
chemoattractant to be loaded into the bays. Following 
loading, the chamber was imaged every 30 s for 
40 frames (20 min) using Q Imaging Retiga 2000R 
camera (Qimaging, Surry, Canada) attached to a 
Zeiss Primovert microscope (Carl Zeiss Imaging, 
Thormwood, NY, USA), allowing cell movement 
to be tracked. Control chemoattractants included 
RPMI (negative control), 10 nM N-Formylmethionyl-
leucyl-phenylalanine (FMLP; positive control) and 
200 ng/mL CXCL8 (positive control). To produce 
the experimental chemoattractants, 200 ng/mL 
CXCL8 was incubated for 1 h at room temperature 
with 100 ppm TiO2 NPs, then centrifuged at 800 ×g 
for 5 min (Geneflow SciSPin Micro, Lichfield, UK) 
to produce an CXCL8 supernatant. The pellet was 
washed, then re-suspended in PBS-1 % BSA to 
produce a second chemoattractant. 100 ppm TiO2 
NPs suspended in PBS-1 % BSA formed the third 
chemoattractant (negative control). One video was 
captured using each potential chemoattractant per 
donor. Fig. 1 shows a diagram of the Insall chamber.
Quantitative analysis of chemotaxis
Analysis was performed according to methods 
described by Roberts et al., (2015). Briefly, image 
frames were processed using the tracking plug-in of 
ImageJ 1.45SR software (National Institutes of Health, 
Bethesda, MD, USA), where a random selection of 15 
cells in the image field of each video were tracked. 
Data gathered were used to calculate cell movement 
in terms of cell speed (movement per unit time in 
any direction), cell velocity (movement per unit time 
towards the chemoattractant) and chemotactic index 
(CI) – a measure of directional accuracy relative to 
the chemoattractant gradient (Andrew and Insall, 
2007). XY co-ordinates of points from the videos 
were analysed using the CircStat toolbox (MATLAB; 
Mathworks, Natick, MA, USA) software to ascertain 
the significance of cell movement over time.
Protein gel electrophoresis
To further identify adsorption of CXCL8 to TiO2 NPs 
and to ascertain any specificity of CXCL8 binding 
over other biomolecules, CXCL8 was exposed to 
TiO2 NPs suspended in simple (BSA only, as before) 
and complex (human serum) media and protein 
gel electrophoresis was performed on centrifuge-
separated supernatants and re-suspended TiO2 
particles. 12 % Bis-Tris protein gels (NuPAGE™ 
Novex™, Invitrogen, Paisley, UK) were employed 
and experimental samples prepared according to 
Table 1. 500 µL of each sample were concentrated 
using centrifuge filters (Amicon Ultra 0.5 mL 3K 
Ultracel, Millipore, Watford, UK) at 350 ×g for 30 min. 
Samples containing TiO2 particles (Fig. 4, lanes 2b, 
3b and 5b) were treated with reducing agent (50 mM 
dithiothreitol, NuPAGE® Sample Reducing Agent, 
Thermo Fisher Scientific, Loughborough, UK) and 
all samples were heated in sample buffer at 70 °C for 
10 min prior to electrophoresis in 2-(N-morpholino) 
ethanesulfonic acid (MES) buffer (NuPAGE® 
MES SDS Running Buffer; Invitrogen) for 20 min. 
Following electrophoresis, the gel was stained for 1 h 
with Imperial Protein Stain (Thermo Fisher Scientific) 
according to manufacturer’s instructions and washed 
in distilled water until the background was clear. 
Images were captured using a lightbox and a Canon 
S110 digital camera (Canon, Tokyo, Japan). See Table 
1 for a complete list of prepared samples.
Fig. 3. Plots of CXCL8 mean concentration against absorbance (arbitrary units) derived from ELISAs 
(n = 3) of the CXCL8 standard (0 ppm) serially-diluted (1 in 10) in (a) standard reagent diluent and (b) 
human serum and for the CXCL8 standard following exposure to 1, 10, 100 and 1000 ppm of TiO2 NPs 
for 1 h, then serially diluted in reagent diluent or human serum (1 in 10) before centrifugation to remove 
insoluble contents. Replicate data points shown (n = 2).
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Results
Direct exposure of CXCL8 to TiO2 NPs resulted in a 
strong and significant depletion in the absorbance 
signal, as detected at the end of the ELISA assay (Fig. 
2a). A similar pattern of behaviour was observed 
with IF-γ, although the signal was not depleted as 
dramatically (Fig. 2b). However, exposure of TNFα, 
IL-1β and IL-6 to TiO2 NPs resulted in no change to 
the ELISA data (Fig. 2c-e). These results suggested 
specificity in the interaction between TiO2 and CXCL8 
(and IF-γ).
 To further investigate the interactions between 
CXCL8 and TiO2 NPs, dose-dependency and dose-
specificity of the binding were studied by titrating 
the concentration of TiO2 NPs against the standard. 
Following NP exposure, NPs were separated by 
centrifugation as before. To further test the specificity 
of CXCL8 adsorption to the TiO2 NPs, the NPs were 
pre-exposed to human serum to establish whether the 
avidity of the binding between CXCL8 and NPs was 
affected by other proteins present in tissue fluids in 
vivo.
 Fig. 3a,b demonstrated a specific interaction 
between CXCL8 and TiO2 NPs in terms of both a 
dose-dependent depletion and specificity in the 
presence of other serum proteins. To test further 
the specificity of binding between the TiO2 NPs and 
CXCL8, protein gel electrophoresis was performed 
to identify proteins present within the samples when 
exposed to TiO2. This technique will qualitatively 
demonstrate if any CXCL8 is bound to TiO2 particles, 
once centrifuged, and if there is a depletion of CXCL8 
signal in samples where the supernatant is tested 
post-centrifugation.
 Samples showing the presence of CXCL8 were 
the positive control: lane 2b (where TiO2 particles 
exposed previously to CXCL8 were separated 
by centrifugation and washed in PBS before 
electrophoresis) and lane 5b (where TiO2 particles 
exposed previously to CXCL8 in 20 % human serum 
were separated by centrifugation and washed in 
PBS before electrophoresis) (Fig. 4). The results 
support ELISA data showing depletion of CXCL8 
present in any supernatants where TiO2 NPs were 
introduced and then removed by centrifugation. 
This strongly implied that the CXCL8 was bound to 
TiO2 NPs and was removed from the supernatant 
during centrifugation. Subsequently, the functional 
consequences of CXCL8 depletion by TiO2 NPs were 
considered by studying the chemotaxis of human 
PMNLs.
 Fig. 5 and 6 showed the altered chemoattractant 
properties of CXCL8 once exposed to TiO2 NPs. Fig. 7 
and 8 demonstrated the loss of directional movement 
of PMNLs towards the supernatant remaining after 
the addition of TiO2 NPs to CXCL8 and centrifugation 
to remove insoluble material, further indicating that 
the CXCL8 was bound to the NPs. Once the NPs were 
re-suspended, they did not act as a chemoattractant; 
therefore, indicating that the association with CXCL8 
was robust. The chemotactic index and velocity 
shown in Fig. 7 and 8 demonstrated a dose-dependent 
reduction in movement of neutrophils towards the 
chemoattractant with increasing amounts of TiO2 
being present. Speed of PMNLs was not affected, 
suggesting that the random movement of cells 
remained consistent but directional accuracy of this 
movement was lost.
Discussion
The extracellular tissue compartment contains a wide 
variety of inflammatory mediators, which vary in 
composition and quantity in both health and disease 
(Dinarello, 2000; Zhang and An, 2007). Inflammatory 
mediator production and function is an essential 
part of the host’s response to infection and injury 
(Soeters and Grimble, 2009; Zhang and An, 2007). 
The current study explored whether TiO2 NPs could 
interfere with the bioavailability and function of 
the inflammatory mediators CXCL8, IFN-γ, IL-1β, 
TNFα and IL-6, which are released by the PMNLs 
and, therefore, are found at inflammatory sites where 
they could be exposed to the TiO2 NPs. Due to its 
Fig. 4. Sections taken from an Imperial Protein Stain 
stained protein gel. Lane 1: 200 pg/mL CXCL8 in PBS 
(high standard used for the ELISA. The faint band 
is due to the low protein concentration used). Lane 
2a: supernatant (SN) from 200 pg/mL CXCL8 in PBS 
plus 1000 ppm TiO2 NPs incubated overnight, then 
centrifuged. Lane 2b: TiO2 NPs centrifuged out from 
the sample in lane 2a, washed in PBS and resuspended 
prior to gel run. Lane 3: SN from TiO2 NPs in PBS only, 
prepared as above. Lane 3b: TiO2 NPs centrifuged out 
and washed in PBS from the sample in lane 3a. Lane 4: 
200 pg/mL CXCL8 in 20 % human serum and 80 % PBS. 
Lane 5a: SN from 200 pg/mL CXCL8 in 20 % human 
serum plus 1000 ppm TiO2 NPs. Lane 5b: TiO2 NPs 
centrifuged and washed in PBS from the sample in lane 
5a. L = ladder, + = positive control (100 ng/mL CXCL8).
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chemotactic properties, there was considerable focus 
on the chemokine CXCL8. Humans are exposed to 
a wide variety of NPs and specifically to TiO2 NPs 
through gastrointestinal absorption, dermal exposure 
and from implanted Ti biomedical devices, where 
in situ generation and accumulation of TiO2 NPs in 
adjacent tissues is demonstrated (Batt, 2017). The 
current study explored one tetragonal crystalline 
form of TiO2 (anatase), which is present in inflamed 
tissues surrounding Ti implanted devices (Addison 
et al., 2012).
 The high surface adsorption energy of NPs is due 
to their large surface to volume ratio. NPs surfaces 
present a large number of unsaturated chemical 
bonds with which biomolecules can interact (Xia et 
al., 2011). Therefore, biological characterisation of 
NPs is complicated by adsorption of proteins and 
biomolecules to their surfaces, a process which is 
competitive and highly dynamic dependent upon 
environmental perturbations (Xia et al., 2011). Current 
opinion is that, in biological media, NPs form a 
corona made up of a strongly bound monomolecular 
layer of small molecules and plasma proteins attached 
to their surfaces, with more loosely adsorbed 
biomolecules attached, which can be exchanged 
with the environment (Cedervall et al., 2007; Lynch 
et al., 2006). However, the physical and chemical 
factors that govern these interactions remain poorly 
understood. In an attempt to further understanding, 
Xia and co-workers develop a biological surface 
adsorption index and identify that, in comparison 
with carbon nanomaterials, TiO2 NPs are predicted 
to weakly adsorb to biomolecules (Xia et al., 2010).
 In this study, it was demonstrated that there 
was selectivity in the interactions between the 
inflammatory mediators CXCL8, IF-γ, IL-1β, TNFα, 
IL-6 and the TiO2 NPs when directly exposed to 
each other (in the presence of BSA), with significant 
reductions in the ELISA signal data for CXCL8 
and to a lesser extent IFN-ɣ, when compared 
to other pro-inflammatory mediators. A clear 
exposure concentration dependency was observed 
for CXCL8 adsorption to TiO2 NP surfaces rather 
than interference with other components of the 
ELISA assay. Exposure of CXCL8 to TiO2 NPs in 
the more complex human serum medium resulted 
in the same pattern of observations as the direct 
exposure to CXCL8 and suggested (although not 
empirically demonstrated) that CXCL8 was strongly 
and selectively adsorbed and did not form a weakly 
adsorbed biomolecular corona. Supporting data 
were generated from the electrophoretic separation 
of CXCL8 and TiO2 NPs, with CXCL8 only detectable 
on the separated NPs, with no significant signal in 
the remaining medium. To demonstrate whether 
the CXCL8 remained bio-available (hence providing 
further information regarding strength of adsorption 
to the NPs), functional assays were performed with 
TiO2 NP exposures in biologically-relevant media. 
CXCL8 is important for PMNL chemotaxis and 
it was demonstrated to act strongly as a PMNL 
chemoattractant, resulting in a significant increase 
Fig. 5. Box-whisker plots showing data 
points plus mean and standard deviation 
(SD) for speed, velocity and chemotactic 
index of PMNLs (n = 14 donors) exposed 
to the positive (FMLP) and negative 
(RPMI) chemoattractant control and to the 
experimental chemoattractants. * indicates 
significant differences (α = 0.05) from RPMI, 
as determined using one-way ANOVA.
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in chemotactic velocity and chemotactic index in 
the Insall chamber assay. Subsequently, TiO2 NP 
addition to CXCL8 eliminated the differences in 
PMNL movement in a dose-responsive pattern, when 
compared with the negative control, suggesting 
a dilution of the CXCL8 gradient across the assay 
measurement bridge.The CXCL8 exposed TiO2 NPs 
also demonstrated no chemoattractant properties, 
indicating again that CXCL8 was strongly adsorbed. 
Given the clear association with CXCL8, these 
findings suggested that the null hypothesis, according 
to which the presence of TiO2 NPs had no selective 
impact on extracellular inflammatory mediator 
adsorption, should be rejected.
 The potential of TiO2 NPs to stimulate CXCL8 
production in human cell lines is documented; 
however, ELISA techniques are employed to identify 
CXCL8 concentrations (Haleem-Smith et al., 2012; 
Wilson et al., 2012). The current study demonstrated 
that ELISA measurement of CXCL8 in the presence 
of TiO2 NPs was unreliable due to the strong 
adsorption of CXCL8 to TiO2 NPs. Although TiO2 
NPs are described as weak adsorbers (Xia et al., 2011), 
the dominant variable affecting TiO2 NPs ability to 
bind biomolecules is the particle size (Horie et al., 
2013). Increasing particle size decreases the surface 
to volume ratio of the particle, affecting its capacity 
to adsorb biomolecules to its surface. It should be 
noted that the TiO2 NPs used in the present study 
agglomerated to some extent once introduced into 
BSA-containing reagent diluent (or human serum), 
but that the CXCL8 binding was not impeded.
 The accumulat ion of  insoluble  TiO 2 i s 
demonstrated in a number of tissues, including 
lungs and peri-implant tissues, where there may be 
simultaneous infection and/or inflammation (Batt, 
2017; Deppe et al., 2002; Fretwurst et al., 2016; Passi 
et al., 2002). The results of this study suggested 
that the TiO2 NPs accumulated in discrete regions 
could preferentially adsorb CXCL8 (and IFN-γ), 
despite the presence of other biomolecules and, 
thereby, modify local inflammatory mediator 
concentrations. In a three-dimensional tissue space, 
a localised reduction of CXCL8 concentration by 
TiO2 NPs would modify (potentially reversing 
completely) the chemoattractant gradients, leading 
to disrupted movement of PMNLs within the tissues, 
thereby delaying bacterial clearance and resolution 
of inflammation. CXCL8 also induces processes 
important in host defences, such as phagocytosis. 
Therefore, the presence of TiO2 NPs would lead 
to localised regions where clearance of microbes 
Fig. 6. Chemotaxis vector plots showing the proportion and directionality of movement of cells in each 
segment during the observation period. The larger the segment, the more cells moved preferentially in 
that direction. The inner numerical notation shows radially the distance moved and the circumferential 
numerical notation the movement angle, where the chemoattractant gradient is normally to 90° (indicated 
by star annotation). Clear directional movement towards the chemoattractant was observed for FMLP 
and CXCL8 by the more vertical direction of the segments.
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Fig. 7. Box-whisker plots showing data 
points, mean and SD for speed, velocity and 
chemotactic index of PMNLs (n = 10 donors) 
exposed to the positive (FMLP) and negative 
(RPMI) chemoattractant control and to the 
experimental chemoattractants (200 ng/mL 
CXCL8 exposed to 1, 10, 100, 1000 ppm of 
TiO2 NPs for 1 h before centrifugation to 
remove the insoluble NPs).
Fig. 8. Chemotaxis vector plots showing the proportion and directionality of movement of cells in each 
segment during the observation period. The inner numerical notation shows radially the distance moved 
and the circumferential numerical notation the movement angle, where the chemoattractant gradient is 
normally to 90° (indicated by star annotation). Clear directional movement towards the chemoattractant 
is observed for FMLP and for CXCL8. However, > 1 ppm TiO2 exposure resulted in non-preferential 
directional movement.
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and cellular debris is compromised. The observed 
depletion of IFN-γ requires further investigation. 
IFN-γ can initially down-regulate the expression 
of CXCL8 by PMNLs, whilst up-regulating the 
expression of the pro-inflammatory inflammatory 
mediators IL-1β and TNFα (Ellis and Beaman, 
2004). IFN-γ also supresses chemotactic migration 
of PMNLs towards FMLP and it is postulated that 
these behaviours indicate that IFN-γ can signal to 
the PMNLs the arrival at the site of inflammation 
(Ellis and Beaman, 2004). A potential consequence 
of TiO2 NP binding would again be a disruption in 
the arrival of PMNLs at the injured site. Furthermore, 
PMNL hyper-reactivity is reported in several 
chronic inflammatory diseases such as periodontitis 
(Matthews et al., 2007). Therefore, further disruption 
of chemotactic accuracy and velocity of neutrophils 
could increase tissue transit times and, thus, 
potentiate PMNL-mediated collateral tissue damage 
in susceptible patients.
Conclusions
TiO2 NPs localise within inflamed peri-implant 
tissues associated with Ti devices. The perturbation 
of CXCL8 activity as a consequence of binding to TiO2 
NPs might be a modifying factor in disease processes, 
such as dental peri-implantitis, where there is chronic 
inflammation of the peri-implant tissues. Whilst this 
study demonstrated the interaction between TiO2 
NPs and CXCL8, IFN-γ also appeared to selectively 
bind to TiO2 NPs, but to a lesser extent. Other 
cytokines may show similar behaviour and further 
investigations are required.
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Discussion with Reviewer
Fackson Mwale: TiO2 NPs stimulate CXCL8 upon 
human neutrophils activation. Does this effect 
decrease as TiO2 is bound to CXCL8?
Authors: TiO2 NPs exposure to human neutrophils 
results in a number of inflammatory events, including 
reactive oxygen species (ROS) generation, neutrophil 
extra-cellular trap (NET) formation and release of 
pro-inflammatory cytokines, including CXCL8. 
Quantification of CXCL8 release is routinely reported 
using ELISA techniques. This study suggested that 
the detected CXCL8 might have been underestimated 
in previous TiO2 NP exposure studies. In vivo, the 
presence of TiO2 NPs might reduce the levels of 
physiologically-available CXCL8.
Fackson Mwale: What is the impact of these studies 
in terms of clinical translation?
Authors: Our mechanistic understanding of materials 
determinants of peri-implant inflammation is not 
fully understood. Generation of nano-scale particles 
following tribocorrosion or mechanically-assisted 
corrosion of metallic implants occurs for a wide 
range of devices. To date, the major focus is on how 
such debris interacts with cellular components of 
the immune response. Here, it was demonstrated 
that TiO2 NPs, which have been detected in peri-
implant tissues associated with dental, craniofacial 
and orthopaedic devices, might exert a more 
subtle influence on peri-implant inflammation, by 
extracellular interactions with signalling molecules 
involved in immune cell recruitment and function.
Fackson Mwale: What are the mechanisms involved 
in CXCL8 depletion and how would you envisage 
tackling the problem of generated TiO2 NPs?
Authors: We agree that these questions are important 
and future work will concentrate on answering them. 
However, we believe that the investigation into 
these mechanisms will be wide ranging and that the 
scope of this study was to highlight and describe the 
interaction along with the potential effects that there 
might be experimentally and clinically.
Editor’s note: The Scientific Editor responsible for 
this paper was Mauro Alini.
